MeRes–1 Study on thin-strut sirolimus-eluting bioresorbable scaffold
MeRes–1 Study. Three-year clinical and two-year multimodality imaging outcomes of thin-strut sirolimus-eluting bioresorbable vascular scaffold in patients with coronary artery disease
MeRes–1 Study. Three-year clinical and two-year multimodality imaging outcomes of thin-strut sirolimus-eluting bioresorbable vascular scaffold in patients with coronary artery disease
Euro PCR 2019
15 years of TAVI, from concept to human application: prospects
en
Prof. Alain Cribier
MyVal-1 Study, THV system: one-year clinical outcomes
en
Dr. Ashok Seth
MeRes–1 Study on thin-strut sirolimus-eluting bioresorbable scaffold
en
Dr. Praveen Chandra
en
Prof. Corrado Tamburino
Stenosi aortica, nuova luce sull'alternativa TAVI-Chirurgia
it
Prof. Corrado Tamburino
Ultrathin stents in complex lesions and multivessel disease
en
Dr. Dariusz Dudek
Which role for surgery in the treatment of left main stenosis
en
Prof. Christian Spaulding
OPTIMUM study: OFDI imaging, optimizing bifurcation stenting
en
Dr. Yoshinobu Onuma
Small vessels: new data from a "Basket Small 2" substudy
en
Prof. Raban Jeger
en
Dr. Giuseppe Musumeci
Al PCR 2019, i risultati della cardiologia interventistica italiana
it
Dr. Giuseppe Musumeci
400,000 patients awaiting TAVI treatment in China
en
Dr. Mao Chen
Strategies to treat complex left main complications
en
Dr. Khaled F. Al-Shaibi
The role of imaging and physiology in PCI optimization
en
Dr. Balbir Singh
CTO intervention in patients with prior CABG
en
Dr. Elliot Smith